Happiness Biotech Group Limited Cash Conversion Cycle 2011-2026 | HAPP

Annual Cash Conversion Cycle Happiness Biotech Group Limited

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
88.5	142	178	93.1	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
178	88.5	126

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Aeterna Zentaris AEZS	-34.3 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
I-Mab IMAB	-1.97 K	-	-	$ 866 M	China
Amarin Corporation plc AMRN	213	$ 14.67	-0.07 %	$ 6.09 B	Irlanda
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Albireo Pharma ALBO	-1.55 K	-	-0.23 %	$ 916 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
Acorda Therapeutics ACOR	117	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	-54.4	-	-	$ 546 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Avid Bioservices CDMO	85.5	-	-	$ 789 M	USA
Advaxis ADXS	-143 K	-	-9.65 %	$ 45.9 M	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Denali Therapeutics DNLI	1.89	$ 19.74	-12.17 %	$ 3.25 B	USA
BioDelivery Sciences International BDSI	340	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.1	-	-	$ 3.74 B	USA
Enlivex Therapeutics Ltd. ENLV	-193	$ 1.09	-9.17 %	$ 22.4 M	Israel
Equillium EQ	16.6	$ 2.06	-	$ 118 M	USA
Esperion Therapeutics ESPR	99.7	$ 2.85	3.26 %	$ 592 M	USA
Eton Pharmaceuticals ETON	115	$ 23.45	-1.64 %	$ 631 M	USA
China SXT Pharmaceuticals SXTC	-108	$ 1.32	-5.2 %	$ 1.88 M	China
CRISPR Therapeutics AG CRSP	1.1 K	$ 47.55	0.98 %	$ 4.28 B	Schweiz
Arbutus Biopharma Corporation ABUS	50	$ 4.45	-1.77 %	$ 853 M	Canada